Results 101 to 110 of about 4,499 (142)

A Simple Dual-Track HPLC-UV Methodology for Monitoring Primary Antiarrhythmic Drugs and Their Active Metabolites in Serum. [PDF]

Pharmaceuticals (Basel)
Kunicki PK, Drózd W, Meszka J.
europepmc   +1 more source

Radiofrequency Ablation for Atrial Arrhythmia After Esophagectomy. [PDF]

JACC Case Rep
Li Y, Guo J, Hu X, Jiang W, Liu Y, Liu X, Wu S.   +6 more
europepmc   +1 more source

Pulsed-Field Ablation of Atrial Tachycardia Arising From the Noncoronary Sinus of Valsalva. [PDF]

JACC Case Rep
Jiang CX, Jin SY, Lin J, Long DY.
europepmc   +1 more source

SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes. [PDF]

BMC Cardiovasc Disord
Chen Z, Zhang L, Chen F, Han Z, Xu W.
europepmc   +1 more source

Multicenter analysis of device-detected atrial fibrillation burden reduction after antiarrhythmic drug initiation. [PDF]

Heart Rhythm O2
Schwartz SM, Peigh G, Culler K, Knight BP, Wan EY, Biviano A, Passman RS.   +6 more
europepmc   +1 more source

In Vitro Metabolism of Doping Agents (Stanozolol, LGD-4033, Anastrozole, GW1516, Trimetazidine) by Human Seminal Vesicle and Liver Fractions. [PDF]

Metabolites
Sternberg J, Peters I, Naumann N, Thomas A, Thevis M.   +4 more
europepmc   +1 more source

Factors influencing the inappropriate dosing of rivaroxaban and edoxaban in Chinese hospitalized patients with atrial fibrillation. [PDF]

Front Cardiovasc Med
Bai Y, Wang J, Li G, Zhou Z.
europepmc   +1 more source

Blocked Atrial Bigeminy as an Unusual Cause of Bradycardia: A Case Report. [PDF]

Int Med Case Rep J
Skakun O, Vandzhura I, Vandzhura Y, Denina R, Zvonar P.   +4 more
europepmc   +1 more source